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ABSTRACT 
Objective: To design, synthesize and in vitro anticancer and antitubercular evaluation of some new isatin derivatives containing azetidinone.  
Methods: Novel azetidinone containing isatin derivatives were designed by using various softwares such as ACD Lab ChemSketch 12.0, Marvin 
Sketch, Molinspiration, PASS and Schrodinger. The designed molecules having required physico-chemical properties, drug likeness and obeying 
Lipinski’s rule of five were selected for the synthesis. These compounds were synthesized by conventional and microwave assisted synthetic 
methods through a series of three steps. The synthesized compounds were subjected to TLC, melting point determination, IR, 1
Results: Ten derivatives (AZ-2, AZ-3, AZ-5, AZ-8, AZ-9, AZ-10, AZ-12, AZ-13, AZ-14 and AZ-15) were selected for synthesis with the help of in-silico 
modeling. In the synthesis, the microwave method took minimum reaction time and gave maximum yield comparing with conventional method. All 
the synthesized compounds showed characteristic peak in IR, 
HNMR and Mass 
spectroscopic studies. The in vitro anticancer activity of selected compounds was evaluated against MCF7 and L929 by MTT assay method. The 
antitubercular activity of selected compounds was evaluated by REMA method.  
1
Conclusion: These results are useful for further investigation in the future. 
HNMR and Mass spectroscopic studies. Based on the Schrodinger Glide XP score, the 
compounds AZ-13, AZ-5 and AZ-3 were selected for in vitro anticancer and AZ-9, AZ-14 and AZ-3 were selected for antitubercular evaluation. The 
compound AZ-13 showed significant anticancer activity particularly against L929 cell line and the compound AZ-9 showed significant 
antitubercular activity comparing with other selected compounds.  
Keywords: Azetidinone containing isatin derivatives, Microwave assisted synthesis, Spectral study, In vitro anticancer activity, Antitubercular activity. 
 
INTRODUCTION 
In nature, isatin is found in plants of the genus Isatis, in Calanthe 
discolor LINDL., and in Couroupita guianensis Aubl., and has also 
been found as a component of the secretion from the parotid gland 
of Bufo frogs and in humans as it is a metabolic derivative of 
adrenaline. Substituted isatins are also found in plants, for example 
the melosatin alkaloids (methoxy phenylpentyl isatins) obtained 
from the Caribbean tumorigenic plant Melochia tomentosa as well as 
from fungi, 6-(3’-methylbuten-2’-yl) isatin was isolated from 
Streptomyces albus and 5- (3’-methylbuten-2’-yl)isatin from 
Chaetomium globosum. Isatin has also been found to be a component 
of coal tar [1]. The biological and pharmacological properties of 
isatin and its derivatives led to extensive use of these compounds as 
key intermediates in organic synthesis [2]. Literature surveys reveal 
that various derivatives of isatin possess diverse activities such as 
antibacterial [2, 3], antifungal [2, 4], antiviral [2, 5], anti-HIV [2, 6] 
antimycobacterial [2, 7] anticancer [2, 8] anti-inflammatory and 
anticonvulsant activities [2]. 
Azetidinones, commonly known as β-lactams, are well-known 
heterocyclic compounds among the organic and medicinal chemists. 
The activity of the famous antibiotics such as penicillins, 
cephalosporins and carbapenems are attributed to the presence of 
2-azetidinone ring in them. Recently, some other types of biological 
activity besides the antibacterial activity have been reported in 
compounds containing 2-azetidinone ring. Such biological activities 
include antifungal, antitubercular, antitumor, inhibition of 
cholesterol absorption and enzyme inhibition activity. The β-lactams 
also serve as synthons for many biologically important classes of 
organic compounds [9]. 
Our ongoing investigations have been directed toward the in-silico 
design, synthesis and pharmacological evaluation of some novel 
isatin derivatives containing azetidinone. 
MATERIALS AND METHODS 
In-silico molecular modification 
In-silico molecular modification was the most important preliminary 
step in the rational drug designing of novel drugs. In the present 
study different proposed derivatives are screened for different 
physico-chemical properties by using different softwares. ACD Lab 
Chemsketch 12.0 and Marvin Sketch were used for 3-D drawing, 
optimizing and calculating various molecular descriptors such as 
hydrophobicity, lipophilicity, steric and electronic parameters of the 
proposed molecules. The Molinspiration software was used for 
calculating LogP values, Lipinski’s rule of five and drug likeness.  
The proposed molecules were screened for whether they obey the 
rule of five or not. The general biological activities of proposed 
molecules were predicted by using PASS (Prediction of activity 
spectra for substances) software and the ADME (absorption,  
distribution,  metabolism  and excretion) profiles were predicted by 
Qik Prop program provided by Schrodinger Maestro. Schrodinger XP 
Glide (Extra precision Grid based ligand docking with energetics) 
program was used for the molecular docking of proposed molecules. 
Ten azetidinone containing isatin derivatives were selected for 






imino}-2, 3-dihydro-indol-2-one. (AZ-5) 
3-{[3-chloro-2-(4-nitrophenyl)-4-oxoazetidin-1-yl] imino}-2, 3-
dihydro-indol-2-one. (AZ-8) 
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Synthesis of selected derivatives 
The selected compounds were synthesized by conventional and 
microwave assisted synthetic methods through a series of three steps. 
Conventional method 
Step-1: Synthesis of Isatin-3-hydrazone 
Isatin (0.01 mole) was dissolved in 20 ml of alcohol. Hydrazine 
hydrate (99%, 0.015 mole) was added to this mixture with stirring 
and the reaction mixture was warmed on the water bath for 10 
minutes and allowed to cool for 3 h in the refrigerator. The resultant 
yellow coloured crystalline solid was filtered, washed repeatedly 
with cold water and finally with cold alcohol. The product obtained 
was dried and recrystallized from alcohol. A single spot on the TLC 
plate established the purity of the compound. The solvent system 
used was toluene: ethyl acetate (7:5). 
Step-2: Synthesis of different Schiff bases 
A mixture of Isatin-3-hydrazone (0.01 mole, 1.61g) in absolute 
ethanol, a few drops of glacial acetic acid and an aromatic aldehyde 
(0.01 mole) were refluxed for 6-8 h. The excess solvent was distilled 
off and the residue was poured on to ice. The separated solid was 
filtered and recrystallized from appropriate solvent. A single spot on 
the TLC plate established the purity of the compound. The solvent 
system used was toluene: ethyl acetate (7:5). 
Yield and melting point of the product were recorded. Ten different 
Schiff bases were synthesized by using different aldehydes. They are  
2-chloro benzaldehyde (0.01 mole, 1.12 ml) was used for the 
synthesis 3-[(2-chlorobenzylidene) hydrazinylidene]-2, 3-dihydro-
indol-2-one. (IIa) 
Para hydroxy benzaldehyde (0.01 mole, 1.22g) was used for the 
synthesis of 3-[(4-hydroxybenzylidene) hydrazinylidene]-2, 3-
dihydro-indol-2-one. (IIb) 
Vanillin (0.01 mole, 3.72g) was used for the synthesis of 3-[(4-
hydroxy-3-methoxybenzylidene) hydrazinylidene]-2, 3-dihydro-
indol-2-one. (IIc) 
Para nitro benzaldehyde (0.01 mole, 1.51g) was used for the 
synthesis of 3-[(4-nitrobenzylidene) hydrazinylidene]-2, 3-dihydro-
indol-2-one. (IId) 
Para fluoro benzaldehyde (0.01 mole, 1.24g) was used for the 
synthesis of 3-[(4- fluoro benzylidene) hydrazinylidene]-2, 3-
dihydro-indol-2-one. (IIe) 
5-bromo salicylaldehyde (0.01 mole, 1.51g) was used for the 
synthesis of 3-[(5- bromo-2-hydroxy benzylidene) hydrazinylidene]-
2, 3-dihydro-indol-2-one. (IIf) 
Para chloro benzaldehyde (0.01 mole, 1.41g) was used for the 
synthesis of 3-[(4- chloro benzylidene) hydrazinylidene]-2, 3-
dihydro-indol-2-one. (IIg) 
Salicylaldehyde (0.01 mole, 0.73 ml) was used for the synthesis of 3-
[(2-hydroxy benzylidene) hydrazinylidene]-2, 3-dihydro-indol-2-
one. (IIh) 
Para methoxy benzaldehyde (0.01 mole, 1.36 ml) was used for the 
synthesis of 3-[(4- methoxy benzylidene) hydrazinylidene]-2, 3-
dihydro-indol-2-one. (IIi) 
Meta nitro benzaldehyde (0.01 mole, 1.51g) was used for the 
synthesis of 3-[(3- nitrobenzylidene) hydrazinylidene]-2, 3-dihydro-
indol-2-one. (IIj) 
Step-3: Synthesis of azetidinone containing isatin derivatives 
A mixture of Schiff’s base (0.01 mole) and triethyl amine (5-6 drops) 
was dissolved in 1, 4-dioxan (50 ml) and cooled with stirring. To this 
mixture, chloroacetyl chloride (0.015 mole, 1.68 ml) was added drop 
wisely within a period of 30 min. The reaction mixture was then 
stirred for an additional 3 hours at room temperature and refluxed 
for 7 h. The reaction mixture was filtered to remove tri ethylamine 
hydrogen chloride and the resultant solution was concentrated, 
cooled and poured into ice-cold water with stirring. The solid thus 
obtained was recrystallized from ethanol. A single spot on the TLC 
plate established the purity of the compound. The solvent system 
used was Methanol: Petroleum ether (1:1). Yield and melting point 
of the product were recorded. 
Schiff bases IIa, IIb, IIc, IId, IIe, IIf, IIg, IIh, IIi, IIj were used for the 
synthesis of compounds AZ-2, AZ-3, AZ-5, AZ-8, AZ-9, AZ-10, AZ-12, 
AZ-13, AZ-14, AZ-15 respectively. 
Microwave assisted synthesis 
Step-1: Synthesis of Isatin-3-hydrazone 
Isatin (0.25g, 1.7 mmole), 55% hydrazine (0.30g, 0.425 mmole) and 
ethylene glycol (1 ml) were added to a 50 ml beaker. The mixture 
was shaken gently to ensure proper mixing. The beaker was then 
covered with a watch glass and irradiated in the microwave oven at 
medium power for 30 seconds. Then the beaker was removed from 
the oven and cooled at room temperature, the mixture was further 
cooled in an ice bath for 5 min. The yellow powders were collected 
in a suction flask, washed with cold ethanol (2.5 ml), and air dried. 
Yield, melting point and R f
Step-2: Synthesis of different Schiff bases 
 value of the product were recorded. 
Isatin-3-hydrazone (0.01 mole), substituted aldehyde (0.001 mole) 
and 1-2 drops of glacial acetic acid were subjected to microwave 
radiation at 360W at an interval for specified time (1-3 minutes). 
The completion of the reaction was checked by TLC. The reaction 
mixture was cooled and poured into cold water. Solid product 
obtained was filtered, dried and recrystallised from ethanol to form 
red crystalline solid. Yield, melting point and R f
Step-3: Synthesis of azetidinone containing isatin derivatives 
 value of the product 
were recorded. 2-chloro benzaldehyde (0.001 mole, 0.112 ml), Para 
hydroxy benzaldehyde (0.001 mole, 0.122g), Vanillin (0.001 mole, 
0.372g), Para nitro benzaldehyde (0.001 mole, 0.151g), Para fluoro 
benzaldehyde (0.001 mole, 0.124g), 5-bromo salicylaldehyde (0.001 
mole, 0.151g), Para chloro benzaldehyde (0.001 mole, 0.141g), 
Salicylaldehyde (0.001 mole, 0.073 ml), Para methoxy benzaldehyde 
(0.001 mole, 0.136 ml), Meta nitro benzaldehyde (0.001 mole, 
0.151g) were used for the synthesis of Schiff bases IIa, IIb, IIc, IId, 
IIe, IIf, IIg, IIh, IIi, IIj respectively. 
A mixture of Schiff’s base (0.01 mole) and triethyl amine (5-6 drops) 
was added to chloroacetyl chloride (0.015 mole, 1.68 ml). Then it 
was irradiated for 3.5 min. in microwave oven and diluted with ice 
cold water. The solid obtained was filtered, washed with water and 
recrystallized from ethanol. Yield, melting point and R f
Characterization of synthesized compounds by spectral study 
 value of the 
product were recorded.  Schiff bases IIa, IIb, IIc, IId, IIe, IIf, IIg, IIh, IIi, 
IIj were used for the synthesis of compounds AZ-2, AZ-3, AZ-5, AZ-8, 
AZ-9, AZ-10, AZ-12, AZ-13, AZ-14, AZ-15 respectively. 
IR Spectrum 
IR spectra were recorded by using KBr pellets in the range of 4000 – 
500 cm-1 on Jasco FTIR Model 4100 Type A to elucidate the 
structure of the compounds. 
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Proton NMR (400 MHz) spectra were recorded by using Bruker ultra 
shield model 400 MHz spectrometer using Di methyl sulphoxide as 
the solvent and Tetra Methyl Silane (TMS) as internal standard. 
Mass spectrum 
Mass spectra of the synthesized compounds were recorded by FAB+ 
ionization mode on JEOL JMS 600 instrument. 
In vitro anticancer activity 
Anticancer activities of selected compounds were evaluated against 
MCF7 (Breast cancer cell line) and L929 (Fibro sarcoma T cells) by 
MTT (3-[4,5-dimethyl thiazol-2yl]-2,5- diphenyl tetrazolium 
bromide) assay method. The cell lines were procured from NCCS, 
(National centre for cell science) Pune, India. 
Sub culturing and maintenance of cell line 
The cell lines were cultured in Dulbecco’s modified eagle’s medium 
(DMEM) supplemented with 10% heat inactivated foetal bovine serum 
(FBS) and incubated at 370C in a humidified atmosphere of 5% CO
Cells were transferred in to 96- well flat bottom plates at the 
concentration of 1×10
2 
Assessment of anticancer activity by MTT assay 
4 cells/ml and incubated at 370C in a 
humidified incubator (5% CO2
 
PR =  
Absorbance of test
Absorbance of control
 x 100 
) for 24 h followed by exposure to 
various concentrations of tested compounds for 48 h. Then 20 µl of 
MTT (3-[4,5-dimethyl thiazol-2yl]-2,5- diphenyl tetrazolium 
bromide) reagent dissolved in PBS (phosphate buffered saline, pH 
7.4) was added to each well and mixed and incubated for an 
additional 4 h. Subsequently, the supernatant was removed, 150 µl 
DMSO (dimethyl sulphoxide) was added to each well for dissolving 
the MTT- formazan crystals. Finally absorbance was recorded at 570 
nm using a micro plate reader with DMSO as a blank and the 
proliferation rate (PR) was calculated by using the following 
equation 
 
Cytotoxicity was calculated as cell growth inhibition rate (IR). 
IR = 100 – PR. 
Antitubercular activity 
Anti-tubercular activity of selected compounds was evaluated by 
Resazurin micro titre assay (REMA) method. Mycobacterium 
tuberculosis H37Rv used for the evaluation was procured from 
MTCC, Chandighar, India. Black view, flat bottom 96-well micro 
plates were used for the experiment. The initial drug dilutions were 
prepared by using dimethyl sulphoxide and subsequent two fold 
dilutions were prepared in the micro plates by using 0.1 ml of 
7H9GC broth. 100 µl of 2000CFU/ml of test organism in 7H9GC 
broth was added to each well of 96 well micro titre plate containing 
test compounds. Three controls- medium only, drug and medium, 
test organism and medium were prepared and all are incubated at 
37°C for seven days. On 7th
RESULTS 
 day alamar blue dye solution (20 μl 
alamar blue solution and 12.5 ml of 20% Tween 80) was added to all 
the wells and the plates were re-incubated at 37 °C for 24 h. Results 
were recorded at 365 nm using a micro plate reader. 
In the present study, in-silico molecular modifications of proposed 
derivatives were done by using different softwares. 3-D drawing, 
optimizing and calculating various descriptors of proposed 
derivatives were done by using ACD Lab Chemsketch 12.0 and 
Marvin Sketch software. The results are shown in table 1.
  
Table 1: Molecular descriptors of proposed derivatives 











AZ-1 C 17H12ClN3O 216.2 ± 7.0 2  605.3 ± 8.0 61.3± 7.0 34.51 ± 0.5  87.06 ± 0.5 
AZ-2 C 17H11Cl2N3O2 225.5 ± 7.0    634.2 ± 8.0 62.4 ± 7.0 36.33 ± 0.5  91.66 ± 0.5 
AZ-3 C 17H12ClN3O 213.5 ± 7.0 3  611.0 ± 8.0 67.0 ± 7.0 34.85 ± 0.5  87.91 ± 0.5 
AZ-4 C 17H10Cl3N3O 234.8± 7.0 2  663.0 ± 8.0 63.5 ± 7.0 38.16 ± 0.5  96.26 ± 0.5 
AZ-5 C 18H14ClN3O 235.2 ± 7.0 4  661.2 ± 8.0 62.4 ± 7.0 37.15 ± 0.5  93.72 ± 0.5 
AZ-6 C 18H14ClN3O 237.9 ± 7.0 3  655.6 ± 8.0 57.6 ± 7.0 36.81 ± 0.5  92.87 ± 0.5 
AZ-7 C 18H14ClN3O 237.9± 7.0 3  655.6 ± 8.0 57.6 ± 7.0 36.81 ± 0.5  92.87 ± 0.5 
AZ-8 C 17H11ClN4O 221.5 ± 7.0 4  650.8 ± 8.0 74.4 ± 7.0 36.75 ± 0.5  92.72 ± 0.5 
AZ-9 C 17H11ClFN3O 219.1 ± 7.0 2  605.5 ± 8.0 58.2 ± 7.0 34.46 ± 0.5  86.93 ± 0.5 
AZ-10 C 17H11BrClN3O 226.0 ± 7.0 3  654.5 ± 8.0 70.2 ± 7.0  37.84 ± 0.5  95.47 ± 0.5 
AZ-11 C 17H11ClN4O 221.5 ± 7.0 4  650.8 ± 8.0 74.4 ± 7.0 36.75 ± 0.5  92.72 ± 0.5 
AZ-12 C 17H11Cl2N3O 225.5 ± 7.0 2  634.2 ± 8.0 62.4 ± 7.0 36.33 ± 0.5  91.66 ± 0.5 
AZ-13 C 17H12ClN3O 213.5 ± 7.0 3  611.0 ± 8.0 67.0 ± 7.0 34.85 ± 0.5  87.91 ± 0.5 
AZ-14 C 18H14ClN3O 237.9 ± 7.0 3  655.6 ± 8.0 57.6 ± 7.0 36.81 ± 0.5  92.87 ± 0.5 
AZ-15 C 17H11ClN4O 221.5 ± 7.0 4  650.8 ± 8.0 74.4 ± 7.0 36.75 ± 0.5  92.72 ± 0.5 
AZ-16 C 17H10ClN5O 226.8 ± 7.0 6  696.2 ± 8.0 88.7 ± 7.0 39.00 ± 0.5  98.38 ± 0.5 
AZ-17 C 19H16ClN3O 256.8 ± 7.0 5  711.5 ±8.0 58.8 ± 7.0 39.46 ± 0.5  99.54 ± 0.5 
AZ-18 C 20H18ClN3O 281.2 ± 7.0 5  756.1 ± 8.0 52.2 ± 7.0 41.42 ± 0.5  104.5 ± 0.5 
AZ-19 C 19H16ClN3O 259.6 ± 7.0 4  705.8 ±8.0 54.6 ± 7.0 39.12 ± 0.5  98.68 ± 0.5 
AZ-20 C 18H14ClN3O 235.2 ± 7.0 4  661.2 ± 8.0 62.4 ± 7.0 37.15 ± 0.5  93.72 ± 0.5 
AZ-21 C 18H14ClN3O 231.4 ± 7.0 2  636.4 ± 8.0 57.1 ± 7.0 36.26 ± 0.5  91.48± 0.5 
AZ-22 C 19H16ClN3O 246.6 ± 7.0 2  667.5± 8.0 53.6 ± 7.0 38.02± 0.5  95.91 ± 0.5 
AZ-23 C 17H13ClN4O 213.0 ± 7.0 2  612.5 ±8.0 68.3 ± 7.0 35.27 ± 0.5  88.97 ± 0.5 
AZ-24 C 19H17ClN4O 257.4 ± 7.0 2  701.6 ± 8.0 55.1 ± 7.0 39.59 ± 0.5  99.86 ± 0.5 
AZ-25 C 21H22ClN5O 298.6 ± 7.0 2  797.9 ±8.0 100.9 ± 3.0 44.66 ± 0.5  112.67 ± 0.5 
AZ-26 C 15H10ClN3O  190.6 ± 7.0 3  547.3 ± 8.0 110.1 ± 5.0 31.41 ± 0.5  96.78 ± 0.5 
The molinspiration software was used to study the LogP values, violation of Lipinski’s rule of five and drug likeness by comparing with already 
existing standard drugs. The results are shown in tables 2, 3 and figures 1, 2.  
 
The ADME profiles of the designed molecules were predicted by 
QikProp program provided by Schrodinger Maestro. The PASS 
software was used to predict the general biological activities of 
proposed molecules. Schrodinger Glide XP software was used for 
predicting the protein-ligand binding modes. In this study, the 
compound having high (-) value is considered as the best one. Of the 
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26 proposed derivatives, 10 derivatives were selected for synthesis 
with the help of these selection parameters. They were named as AZ-
2, AZ-3, AZ-5, AZ-8, AZ-9, AZ-10, AZ-12, AZ-13, AZ-14 and AZ-15. The 
selected compounds were synthesized by conventional and 
microwave assisted synthetic methods through a series of three 
steps. The general scheme for the synthesis is presented in figure 3.
 
Table 2: Lipinski’s rule analysis of standard drugs and proposed derivatives 
Compound MiLog P M. W n. HDO n. HAC n. rotb n. violation 
Isoniazid -0.89 137.14 3 4 1 0 
Ethambutol 0.35 204.314 4 4 9 0 
Mechlorethamine 1.554 156.056 1 0 4 0 
Cyclophosphamide 0.755 261.081 4 1 5 0 
AZ-1 2.903 322.755 5 1 2 0 
AZ- 2 3.533 360.2 5 1 2 0 
AZ-3 2.423 341.754 6 2 2 0 
AZ-4 4.187 394.645 5 1 2 0 
AZ-5 2.242 370.78 7 2 3 0 
AZ-6 2.911 355.781 6 1 3 0 
AZ-7 2.935 355.781 6 1 3 0 
AZ-8 2.862 370.752 8 1 3 0 
AZ-9 3.066 343.745 5 1 2 0 
AZ-10 3.628 420.65 6 2 2 0 
AZ-11 2.814 370.752 8 1 3 0 
AZ-12 3.581 360.2 5 1 2 0 
AZ-13 2.843 341.754 6 2 2 0 
AZ-14 2.959 355.781 6 1 3 0 
AZ-15 2.838 370.752 8 1 3 0 
AZ-16 2.748 415.749 11 1 4 1 
AZ-17 2.258 401.806 8 2 4 0 
AZ-18 2.929 415.833 8 1 5 0 
AZ-19 2.549 385.807 7 1 4 0 
AZ-20 2.447 371.78 7 2 3 0 
AZ-21 3.303 339.782 5 1 2 0 
AZ-22 3.728 353.809 5 1 2 0 
AZ-23 1.979 340.77 6 3 2 0 
AZ-24 3.005 368.824 6 1 3 0 
AZ-25 3.035 411.893 7 1 4 0 
AZ-26 2.16 315.716 6 1 2 0 
M. W- molecular weight; nHDO- number of hydrogen bond donar; nHAC- number of hydrogen bond acceptor; n. rotb- number of rotatable bonds. 
 
Table 3: SMILES and Log P values of standard drugs and the derivatives selected for the synthesis 
Compound Substitution Smile Notation Log P 
Isoniazid  -- O=C(NN)c1ccncc1 -0.65 
Ethambutol -- CCC(NCCNC(CC)CO)CO -0.41 
Mechlorethamine -- C1CCN(C)CCC1 0.91 
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Molinspiration bioactivity score v2011.06 
GPCR ligand -0.30 
Ion channel modulator -0.45 
Kinase inhibitor -0.05 
Nuclear receptor ligand -0.66 
Protease inhibitor -0.50 
Enzyme inhibitor -0.30 
 
 Fig. 1: Molinspiration score of compound AZ-9 
 
 










Molinspiration bioactivity score v2011.06 
GPCR ligand -0.31 
Ion channel modulator-0.42 
Kinase inhibitor -0.09 
Nuclear receptor ligand-0.58 
Protease inhibitor -0.49 
Enzyme inhibitor -0.25 
 
Fig. 2: Molinspiration score of compound AZ-13 
 
Table 4: Comparison of microwave and conventional synthetic methods 
Compound Microwave Conventional 
Time (min) Yield (%) Time (min) Yield (%) 
AZ-2 3.5 77.00% 420 63.5% 
AZ-3 3.5 78.00 % 420 64.5% 
AZ-5 3.5 71.00 % 420 59.00% 
AZ-8 3.5 78.00 % 420 64.5% 
AZ-9 3.5 80.5% 420 68.00% 
AZ-10 3.5 71.00% 420 59.00% 
AZ-12 3.5 87.00% 420 70.00% 
AZ-13 3.5 80.5% 420 68.00% 
AZ-14 3.5 77.00% 420 63.5% 
AZ-15 3.5 87.00% 420 70.00% 
Purity of the synthesized compounds was ascertained by TLC and melting point determination by open capillary tube method. The results are 
shown in table 5. 
 
Table 5: Physical characterization data of synthesized compounds 
Compound Mol. formula Mol. Wt. Melting point (°C) R f 
AZ-2 C17H11Cl2N3O 360.2 2 236-2380 0.75 C 
AZ- 3 C17H12ClN3O 341.754 3 243-2460 0.91 C 
AZ-5 C18H14ClN3O 370.78 4 237-2390 0.95 C 
AZ-8 C17H11ClN4O 370.752 4 254-2560 0.91 C 
AZ-9 C17H11ClFN3O 343.745 2 255-2570 0.72 C 
AZ-10 C17H11BrClN3O 420.65 3 226-2290 0.95 C 
AZ-12 C17H11Cl2N3O 360.2 2 256-2590 0.80 C 
AZ-13 C17H12ClN3O 341.754 3 243-2450 0.72 C 
AZ-14 C18H14ClN3O 355.781 3 240-2420 0.75 C 
AZ-15 C17H11ClN4O 370.752 4 251-2530 0.80 C 
The synthesized compounds were characterized by IR, 1HNMR and Mass spectroscopic methods. The IR spectra of the synthesized compounds are 
presented in table 6, 1HNMR report for compound AZ -12 is shown in Graph 1 and the mass spectrum report for compound AZ – 13 is shown in 
Graph 2. 
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Reflux for 6h in absolute ethanolSTEP II
STEP I
N-substituted isatin - 3 -hydrazone
1,4 -dioxan







Azetidinone substituted isatin derivatives
STEP III
 
Fig. 3: General scheme for the synthesis of azetidinone containing isatin derivatives 
The results showed that the microwave assisted synthetic method took a minimum reaction time but gave high yield comparing with conventional 
method. The results are shown in table 4.  
 
Table 6: IR spectra of synthesized compounds 
Compound  IR Peaks (cm-1  )  
 AZ-2 3488.41 (N-H str), 3034.8 (Ar C-H str), 1716.99(C=O),1647.64 (C=N str), 1485.82(CH-N str), 760.138 (C-Cl str) 
AZ-3 3568.72(OH str), 3450.55 (N-H str),3031.12(Ar-CH), 1712.2 (C=O str), 1642.02 (C=N str), 1489.3(CH-N str),740.82(C-Cl) 
AZ-5 3650.37(OH str),3460.16 (N-H str), 3035.13 (Ar C-H str), 1710.34(C=O str), 1635.02(C=N str), 1470.85(CH-N str), 1135.54(C-
O-C str), 780.384(C-Cl) 
AZ-8 3450.05(N-H str), 3035.66(Ar-CH str), 1721.41(C=O str), 1652.33 
(C=N str),1550.2 (N=O), 1465.78(CH-N str),981.93(N-O),755.99(C-Cl) 
AZ-9 3410.225(N-H Str), 3032.145(Ar-CH Str), 1725.625(C=O Str), 1650.23(C=N Str), 1340.35(C-F Str),757.134(C-Cl) 
AZ-10 3590.237(O-H Str), 3465.12(N-H Str), 3030.005(Ar-CH), 1712.36(C=O Str), 769.65(C-Cl), 595.2(C-Br) 
AZ-12 3470.56(N-H Str), 3029.70(Ar-CH), 1713.41(C=O Str), 1645.13(C=N Str), 1483.79(CH-N Str), 7580352(C-Cl) 
AZ-13 3550.72(O-H Str), 3400.55(N-H Str), 3032.44(Ar-CH Str), 1715.16(C=O), 1647.88(C=N), 1470.03(CH-N), 761.58(C-Cl) 
AZ-14 3465.22(N-H Str), 3040.37(Ar-CH Str), 1710.34(C=O Str), 1635.02(C=N), 1470.85(CH-N Str), 1135.54(C-O-C), 780.384(C-Cl) 
AZ-15 3456.26(N-H Str), 3032.76(Ar-CH), 1741.21(C=O), 1656.69(C=N), 1556.32(N=O), 982.33(N-O), 760.11(C-Cl) 
 
Table 7: Schrodinger Glide XP scores of synthesized compounds for anticancer activity 
Target PDB  
ID 
Compound  Glide 
 score 



















Graph 2: Mass spectrum report for compound AZ – 13 




Fig. 4: Docking image of AZ-13 to Gamma tubulin – 1Z5W 
 
The tested derivatives showed cytotoxic activity against the tested 
cancer cell lines. But the compound AZ-13 showed significant 
anticancer activity particularly against L929 cell line. The results are 
shown in table 8. 
Based on the Schrodinger Glide XP score, the compounds AZ-13, AZ-
5 and AZ-3 were selected for in vitro anticancer evaluation against 
MCF7 and L929 cell lines by MTT assay method. Docking scores for 
anticancer activity are presented in table 7 and the docking image of 
AZ-13 is shown in fig based on the Schrodinger Glide XP score, the 
compounds AZ-9, AZ-14 and AZ-3 were selected for antitubercular 
evaluation.  
Docking scores for antitubercular activity are presented in table 9 
and the docking image of AZ-9 is shown in figure 5. All the selected 
compounds showed anti-tubercular activity. But the compound AZ-9 
showed significant anti-tubercular activity comparing with other 
selected compounds. The results are shown in table 10. gure 4. 
  





AZ 3 AZ 5 AZ9 AZ13 Doxorubicin Paclitaxel 
MCF7 L929 MCF7 L929 MCF7 L929 MCF7 L929 MCF7 L929 
 1  17.40  35  33.18  37  13.42  33  36.75  41  57.17  52.28 
10 22.12 43 36.84 45 19.25 39 43.62 52 62.76 62.1 
100 34.45 50 42.76 52 32.33 46 45.83 60 63.70 75.69 
250 42.34 56 47.44 59 36.53 53 49.24 69 65.37 82.61 
500 49.52 64 51.43 67 41.24 60 54.35 74 69.54 88.37 
Con. – Concentration 
 
Table 9: Schrodinger Glide XP scores of synthesized compounds for anti tubercular activity: 
Target PDB ID Compound  Glide score 
MYCOBACTERIUM TUBERCULOSIS- 
CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) 












In the present study, the in-silico molecular modeling studies were 
carried out for the selection of suitable drug candidates prior to wet 
lab synthesis. In-silico studies were performed on 26 analogues by 
means of ACD Lab ChemSketch 12.0, Marvin Sketch, Molinspiration, 
PASS, and Schrodinger. Of the proposed 26 analogues, 10 candidates 
were chosen for wet lab synthesis.  
These compounds were synthesized by both conventional and 
microwave methods. The later one took minimum reaction time but 
gave maximum yield comparing with conventional method. The 
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synthesized compounds were subjected to TLC, melting point 
determination, IR, 1
 
HNMR and Mass spectroscopic studies. All these 
evaluation ensured the synthesized compounds. On docking with 
Gamma-Tubulin (1Z5W), the compounds AZ-13, AZ-5 and AZ-3 
showed good glide score, these compounds were subjected to in 
vitro anticancer evaluation against MCF7 and L929 cell lines by MTT 
assay method. The results showed that the compound AZ-13 having 
significant anticancer activity particularly against L929 cell line. Of 
course this compound needs further studies such as toxicity and in 
vivo evaluation. On docking with Cytochrome P450 14 Alpha-Sterol 
Demethylase (CYP51), the compounds AZ-9, AZ-14 and AZ-3 showed 
good glide score, these compounds were selected for antitubercular 
study by REMA method. The compound AZ-9 showed significant 
antitubercular activity comparing with other selected compounds. 
This compound also needs further study. So it is clear that further 
works needed to be done in the future for the development of 
clinically useful chemotherapeutic agents. Fig. 5: Docking image of AZ- 9 to CYP51 - 1EA1
 




AZ 3 AZ 9 AZ 10 AZ 14 
0 0 0 0 0 
50 41 47 39 44 
100 50 55 47 52 
150 61 66 59 64 
200 72 77 68 75 
250 76 83 73 80 
Conc. – Concentration 
 
CONCLUSION 
In summary, the prime objective of the present work was to design, 
synthesize and biologically screen some of the azetidinone 
containing isatin derivatives. The present work involved the 
preliminary in-silico screening of various analogues to analyze for 
their molecular descriptors using computational softwares. 
Derivatives with desired physicochemical properties, obeying 
Lipinski Rule of Five and those with no violations were chosen for 
wet lab synthesis. Synthesis of ten analogues was performed and the 
purity of the same was ascertained by consistency in melting point 
and R f
1. Joaquim FM da Silva, Simon J Garden, Angelo C Pinto. The 
chemistry of isatins: a review from1975 to 1999. J Braz Chem 
Soc 2001;12(3):273-324. 
 value. The compounds were characterized by IR, NMR and 
Mass spectral studies. Selected derivatives were screened for 
antimycobacterial and anticancer activity. Activities of the screened 
analogues were comparable, reflecting the novelty of azetidinone 
analogues with improved biological activity. Azetidinone and its 
analogues have established themselves as good antibiotics. This 
work has proved the biological action of some of the synthesized 
analogues as antimycobacterial and anticancer agents. The 
analogues can be subjected to further detail pharmacological 
screening for consideration as drug candidates. 
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